Vitamin K: A potential Liver Cancer treatment way

Sofia Dahlberg, Ulf Schött

Research output: Contribution to journalReview articlepeer-review


A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago
Original languageEnglish
Pages (from-to)049-052
JournalArchives of Hepatitis Research
Issue number2
Publication statusPublished - 2017

Subject classification (UKÄ)

  • Cancer and Oncology


Dive into the research topics of 'Vitamin K: A potential Liver Cancer treatment way'. Together they form a unique fingerprint.

Cite this